In a phase 2b randomized clinical trial, bofanglutide demonstrated a strong efficacy in reducing blood sugar in people with type 2 diabetes
That should be evaluated promptly
75% of the women with PCOS suffer from insulin resistance, which makes weight loss even more difficult
Combined with biomarker data and insurance details, this personalized information helps justify whether premium-priced branded medications, cost-effective compounded options, or combination protocols best fit your clinical profile and budget constraints
US customs data reveals peptide-based substance imports from China nearly doubled from $164 million in early 2024 to $328 million in early 2025, reflecting surging demand
Patients often report not only weight loss but also improvements in energy, motivation, and their relationship with food